News | Ablation Systems | September 15, 2015

Texas Heart Hospital First in United States to Use EpiAccess System

New system offers better visualization of the pericardial cavity during epicardial ablation than traditional fluoroscopic imaging

Texas Cardiac Arrhythmia Institute, TCAI, first in United States, EpiAccess System, epicardial ablation

Image courtesy of EpiEP

September 15, 2015 — The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently became the first facility in the United States to use the EpiAccess system to access the pericardial cavity of the heart during an epicardial ablation. The procedure was performed by Andrea Natale, M.D., FHRS, FACC, FESC, cardiac electrophysiologist and executive medical director of TCAI, and J. David Burkhardt, M.D., FACC, cardiac electrophysiologist at TCAI.

The EpiAccess System includes both a single-use needle with an incorporated pressure sensor and a pressure monitor that uses proprietary algorithms to analyze pressure frequency data. Real-time information is presented in an intuitive and easy-to-understand display, which informs physicians of needle tip location to simplify access and to reduce the risk of complications commonly associated with blind sticks.

"The new EpiAccess system may decrease the amount of time it takes to perform these technically challenging procedures and, more importantly, it can increase patient safety and reduce the risk of complications," Natale said. "We are pleased to be among the first facilities in the nation to offer this technology."

Minimally invasive epicardial access is currently performed using fluoroscopic imaging, which can be challenging to use given the difficulty in distinguishing soft tissue features and limitations of two-dimension imaging. Because the pericardial cavity is less than one millimeter thick, the precision of needle placement is critical.

In addition to reducing the risk of complications, such as pericardial effusions, and improving patient outcomes, the EpiAcess System may also reduce the amount of radiation used during these types of procedures.

Access to the pericardial cavity of the heart is necessary when performing complex cardiac ablations and left atrial appendage closures, among other procedures.

For more information:

Related Content

Abbott Secures FDA Approval for MRI Compatibility on Ellipse ICD
Technology | Implantable Cardioverter Defibrillator (ICD)| September 22, 2017
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Overlay Init